Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine Tumours
暂无分享,去创建一个
C. Denkert | D. Bartsch | A. Ramaswamy | E. Maurer | P. Di Fazio | M. Jesinghaus | A. Rinke | Albert Grass | Jelte Poppinga | Bettina J Lehman
[1] B. Goichot,et al. 18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors , 2022, The Journal of Nuclear Medicine.
[2] M. Luster,et al. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms , 2021, Journal of neuroendocrinology.
[3] M. Kendrick,et al. Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumors , 2021, Journal of surgical oncology.
[4] J. Garber,et al. Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs) , 2021, JCO precision oncology.
[5] D. Bartsch,et al. Prognostic Factors in Curative Resected Locoregional Small Intestine Neuroendocrine Neoplasms , 2021, World Journal of Surgery.
[6] E. Larsson,et al. Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine , 2020, Nature Communications.
[7] A. Bellizzi. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can Brown do for you? , 2019, Human pathology.
[8] He Xiao,et al. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors. , 2019, Pathology, research and practice.
[9] J. Cates,et al. Should Ki67 immunohistochemistry be performed on all lesions in multifocal small intestinal neuroendocrine tumours? , 2018, Histopathology.
[10] H. Schildhaus,et al. Der prädiktive Wert der PD-L1-Diagnostik , 2018, Der Pathologe.
[11] W. Ito,et al. High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs. , 2018, Human pathology.
[12] A. Gangi,et al. Multifocality in Small Bowel Neuroendocrine Tumors , 2018, Journal of Gastrointestinal Surgery.
[13] T. O'Dorisio,et al. Is Multifocality an Indicator of Aggressive Behavior in Small Bowel Neuroendocrine Tumors? , 2017, Pancreas.
[14] E. Ingelsson,et al. A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors , 2017, Endocrine-related cancer.
[15] I. Endo,et al. Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors , 2017, Digestion.
[16] A. Bellizzi,et al. Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival , 2017, Annals of Surgical Oncology.
[17] J. Berlin,et al. Phase 3 Trial of 177Lu‐Dotatate for Midgut Neuroendocrine Tumors , 2017, The New England journal of medicine.
[18] E. Krenning,et al. ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum , 2016, Neuroendocrinology.
[19] Michael Goodman,et al. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies , 2015, Modern Pathology.
[20] Richard A Armstrong,et al. When to use the Bonferroni correction , 2014, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[21] S. Baldus,et al. Neuroendokrine Neoplasien des distalen Jejunums und Ileums , 2014, Der Pathologe.
[22] T. Gress,et al. ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas , 2011, Neuroendocrinology.
[23] E. Baudin,et al. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary , 2011, Neuroendocrinology.
[24] B. Wiedenmann,et al. Neuroendocrine tumors of midgut and hindgut origin: Tumor‐node‐metastasis classification determines clinical outcome , 2011, Cancer.
[25] D. Shutt,et al. Tomography Imaging Targets in Ileal and Pancreatic Neuroendocrine Tumors , 2010 .
[26] A. Scarpa,et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system , 2007, Virchows Archiv.
[27] L. Sobin,et al. Carcinoids of the jejunum and ileum , 1997, Cancer.
[28] P. Neuhaus,et al. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. , 1996, Gut.
[29] M. Schwaiger,et al. Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT , 2008, European Journal of Nuclear Medicine and Molecular Imaging.